Found: 7
Select item for more details and to access through your institution.
RHOA Therapeutic Targeting in Hematological Cancers.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 3, p. 433, doi. 10.3390/cells12030433
- By:
- Publication type:
- Article
Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2546, doi. 10.1002/1878-0261.13386
- By:
- Publication type:
- Article
G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kdi dual therapy.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1130052
- By:
- Publication type:
- Article
Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5601, doi. 10.3390/cancers14225601
- By:
- Publication type:
- Article
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 923, doi. 10.3390/cancers14040923
- By:
- Publication type:
- Article
Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 860, doi. 10.3390/cancers14040860
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in B-Cell Lymphoma.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 214, doi. 10.3390/cancers13020214
- By:
- Publication type:
- Article